
Sign up to save your podcasts
Or
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.
4.9
639639 ratings
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.
139 Listeners
1,867 Listeners
322 Listeners
535 Listeners
504 Listeners
254 Listeners
3,331 Listeners
1,114 Listeners
399 Listeners
712 Listeners
196 Listeners
254 Listeners
367 Listeners
289 Listeners
388 Listeners